In early corporate news, AstraZeneca receives EU approval for a bladder cancer therapy, and a subdued housing market leaves MJ Gleeson eyeing adjusted pretax profit at the lower end of current market ...

Reports are circulating that AstraZeneca shares could be moving off the London exchange with its CEO favouring a US market ...

Just days after President Donald Trump was elected in November, AstraZeneca unvei | AstraZeneca CEO Pascal Soriot is plotting ...

AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the ...

In turn, while the overall impact from them is still yet to be seen, Mr Bailey says tightening rates further could be more ...

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

(Reuters) -AstraZeneca chief executive Pascal Soriot is considering moving the company's stock market listing to the United ...

Human Magic, the global employer brand agency behind creative strategies for brands like Nike, Microsoft, Apple, LinkedIn, ...

(Reuters) -AstraZeneca said on Tuesday that U.S. regulators have approved its precision drug Datroway to treat a type of lung ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best UK stocks to invest in. Like most of the world, the United Kingdom is also facing ...

Soriot's remarks came as the United Kingdom-based pharmaceutical giant announced on Friday an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D center, together ...